Chronic Diseases Raise Demand for Customized Treatments Driving Cell Culture Market
The high incidence of chronic diseases and the growing demand for treating them in a customized way has been the driving force behind the global cell culture market. The increasing investments in the research and development of newer products in the pharmaceutical sector and growing applications of cell culture have collectively propelled the overall market. The evolution of genetic engineering, artificial organs, and recombinant DNA technology, amongst others have made cell culture market integral to the overall healthcare industry.
Transparency Market Research reports that the opportunity in the global cell culture market will be worth US$11.3 bn in 2022 as against US$6 bn in 2013. During the forecast period of 2014 to 2022, the global market is anticipated to clock a CAGR of 7.1%. The burgeoning demand for biopharmaceuticals will also benefit this market as it will offer specific solutions taking into consideration the genetic makeup of the patient along with the physiological and biological needs. The growing demand for and adoption of artificial organs will also benefit the market in the forecast period.
Technological Advancements Increase Application Options of Cell Culture across North America
North America has been identified as the leading geographical segment of the global cell culture market. Valued at US$2.2 bn in 2014, the market is anticipated to reach US$3.7 bn by 2022 due to the high incidence of cancer cases and other metabolic diseases. The region has also witnessed the introduction of new cell culture technologies and protocols with ongoing technological advancements such as multi-faceted bioprocessing systems, the development of 3D cell culture, and automated cell culture instruments.
The increasing emphasis on intensive research and development activities to widen the scope of applications in carcinogenesis, mutagenesis, and large-scale manufacturing of biological compounds such as therapeutic proteins and vaccines has also played a critical role in putting North America in the leading position. The high disposable income of the consumers and the supportive healthcare infrastructure is also anticipated to boost the North America cell culture market.
Cell Culture Media Segment Leads with 8.8% CAGR
According to the report, the cell culture media segment held the leading share in the global market and is anticipated to be the fastest growing segment at a CAGR of 8.8% between 2014 and 2022. The consistent efforts to provide high-quality media for achieving accurate and reproducible results are expected to keep the cell culture media segment at the forefront in the coming years. The commercialization of stem cells and ongoing technological developments are expected to support the shift to serum-free animal-derived media in the near future. Experts have also observed that there has been a considerable demand for medial powders and ready-to-use liquid media.
Some of the key players operating in this market are GE Healthcare, Sigma-Aldrich Corporation, BD Biosciences, VWR International, EMD Millipore, Lonza Biosciences, and Thermo Fisher Scientific, Inc. Players are focusing on introducing improved technologies such as 3D cell culture techniques to deliver better results as compared to 2D cell cultures. Players will proactively work towards meaningful collaborations, mergers and acquisitions, and value additions to product portfolios to remain competitive in the global market.
The global cell culture media, sera and reagents market is witnessing impressive growth due to the increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life sciences industry, the cell culture market has witnessed significant growth in terms of scope as well as adoption by the end-users. The double-digit growth in the biotechnology and biopharmaceutical industries is the major factor likely to boost the growth of the cell culture media, sera and reagents market in the near future.
The market has been extensively analyzed on the basis of media, sera, reagents, and geography. Cell culture media are further segmented into chemically defines media, classical media, lysogeny broth, protein-free, serum-free and specialty media; segment for cell culture sera is sub-segmented into fetal bovine serum, newborn calf and adult bovine serum and others; and reagents segmented to further divided into albumin, amino acids, attachment factors, growth factors and cytokines, protease inhibitors, and others. Albumin market is further studied for human serum albumin, bovine serum albumin, and recombinant serum albumin. Growth factors and cytokines market is studied for insulin-like growth factors, interleukins and interferons, tumor necrosis factors and other growth factors and cytokines. The others reagents segment is further divided in porcine trypsin, recombinant trypsin, thrombin and miscellaneous reagents.
Each of the segments has been analyzed in detail for market trends, recent developments, outlook, and opportunities. The report provides current and future market size for each segment and sub-segment for the period from 2013 to 2023, in terms of revenue in USD million considering 2013 and 2014 as the base years. The compound annual growth rate (% CAGR) for each market segment has been provided for the forecast period from 2015 to 2023 along with the estimations of market size.
Geographically, the global cell culture media, sera and reagents market has been classified into five major regions: North America (the U.S., Canada), Europe (Germany, the U.K., Rest of Europe), Asia Pacific (Japan, China, India, Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Rest of the World (RoW) (Israel and Russia). The regions have been further segmented by media, sera and reagents. The current and future market sizes in terms of revenue (USD million) of these regional markets and their major countries have been provided in the report for the period from 2013 to 2023, with their growth rate (%) for the period from 2015 to 2023. The study also offers a list of recommendations and highlights of the market for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process.
The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints, and opportunities that influence the current and future status of the cell culture industry. The report also covers market attractiveness analysis, Porter’s Five Forces Analysis and key market share analysis in the market overview section, in order to give a thorough analysis of the overall competitive scenario in the global cell culture media, sera and reagents market.
The competitive landscape section of the report includes the market share analysis of major players in the cell culture media, sera and reagents market for the year 2013. The report concludes with the company profiles section that includes key information about the major players in the market. Key players profiled in this report include BD Biosciences, Corning Incorporated, EMD Millipore, GE Healthcare, Lonza Group, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., VWR International, LLC, and PromoCell GmbH. Each of these players is profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments.
The global cell culture media, sera, and reagents market has been segmented as given below:
Global Cell Culture Media Market Revenue, by Type
- Chemically defined
- Lysogeny broth (LB)
Global Cell Culture Sera Market Revenue, by Type
- Fetal Bovine
- Newborn Calf and Adult Bovine Sera
Global Cell Culture Reagents Market Revenue, by Type
- Human Serum Albumin (HSA)
- Bovine Serum Albumin (BSA)
- Recombinant Serum Albumin (RSA)
- Amino Acids
- Attachment Factors
- Growth Factors & Cytokines
- Insulin-like Growth Factors (IGF)
- HumanKine Growth Factors and Cytokine
- Tumor Necrosis Factor (TNF)
- Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others)
- Porcine Trypsin
- Recombinant Trypsin
- Miscellaneous Reagents
Global Cell Culture Media, Sera, and Reagents Market Revenue, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America (LATAM)
- Rest of Latin America
- Rest of the World (RoW)
- Rest of RoW